- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03579056
GeRIatric Multidisciplinary Meeting (GRIMM)
Modeling of the Geriatric Multidisciplinary Meeting of the Angers University Hospital
The primary objective of this study is to develop a typology of patients referred to the Geriatric Multidisciplinary Meeting (GMM) according to their demographic and clinical profile.
The secondary objectives are:
- To distinguish the different types of answers given by the GMM according to the demands and situations.
- To study the factors associated with the orientation proposed by the GMM
- To examine the adequacy between the orientation proposed by the GMM and the pathway actually taken
- To compare the diagnoses made during the following year with the data collected during the GMM
Study Overview
Status
Conditions
Detailed Description
Increasing attention is paid to care pathways for elderly according to the principle of good care applied to the right patient at the right time and in the most appropriate care structure.
Since 2007, the geriatric mobile team (GMT) of the Angers University Hospital has formalized a geriatric multidisciplinary meeting (GMM) in connection with the geriatric network and branch of the geographical sector, in order to optimize the provision of care for elderly patients at the territorial level.
The weekly GMM brings together physicians from the geriatric department (GMT, acute care unit), memory center, long-term care and skilled nursing facilities, cognitive behavioral unit, psychiatry, retirement home, the local geriatric network of the city of Angers, the local information and coordination center, the home for autonomy and integration of Alzheimer patients (MAIA) and specialized Alzheimer (ESA) teams. Requests come either University Hospital services or from outside, via a standardized form. If necessary, additional data collection is carried out before the meeting by telephone with the patient, his family or the general practitioner. A letter explaining the decision of the GMM is sent to the applicant physician and to the general practitioner and recorded in the patient file.
Collegial guidance decisions within the health care system seem to follow implicit rules. Given the growing number of files presented, the investigators want to theorize the adopted mode of reflection.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Angers, France, 49933
- Angers University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All the files discussed in GMM in the year 2015 following a request for geriatric care addressed to the Geriatrics department of the UH
Exclusion Criteria:
- No one
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The demographic characteristics and medico-social data provided by the physician and the family at the time of the consultation request
Time Frame: baseline
|
The demographic characteristics are age, sex, marital status, place of life, career, presence of un/formal assistance, …
|
baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The answer given by the GMM
Time Frame: baseline
|
This outcome is assessed by the guidance proposal issued by GMM
|
baseline
|
|
The orientation proposed by the GMM
Time Frame: baseline
|
The recommendations made by GMM
|
baseline
|
|
The adequacy between the orientation proposed by the GMM and the pathway actually taken : back in the previous structure, hospitalization, reorientation, entry to a nursing home, other :
Time Frame: baseline and during the following year
|
The course of care carried out at the Angers UH after the GMM
|
baseline and during the following year
|
|
The diagnoses made during the following year with the data collected during the GMM : Alzheimer's disease, mixed dementia, body lewy, Parkinson's disease, frontotemporal dementia, vascular dementia, other
Time Frame: baseline and during the following year
|
Diagnoses carried out at the Angers UH after the GMM
|
baseline and during the following year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2017-06
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.